TRIALS,TRIBULATIONS & BREAKTHROUGHS: THE FUTURE OF LEGAL PSYCHEDELICS
A discussion about: breakthroughs achieved by clinical and therapeutic trials that have used MDMA and ketamine as tools to help people with depression and PTSD, psilocybin’s efficacy in treating addictions, current and future legal psychedelics for health and wellness, why psychedelics are different than any other drugs and, are psychedelics the medical cure neglected groups like Vets and frontliners and many others need to combat mental health challenges?
Featuring: Rick Doblin PhD [MAPS], Dr Matthew Johnson PhD, [Johns Hopkins], Adam Wright [Field Trip Health]
Hosted By: Shannon Smadella [World Psychedelics Day, Insight Global]
Panel Sponsored By:
FIELD TRIP HEALTH
Field Trip’s approach and treatment programs are based on mounting evidence and also honor the rituals and wisdom, passed down through the generations. Being a psychedelic-assisted therapy program means that we have integrated psychedelic medicine with psychotherapy to treat conditions like treatment resistant depression and PTSD.
Special Thanks to our Event Presenting Sponsor:
KATA - KETAMINE ASSISTED THERAPY ASSOCIATION OF CANADA